Overview

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells of by stopping them from dividing. Pemetrexed disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of giving pemetrexed disodium and docetaxel together in treating patients with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
University of Arizona
Collaborator:
National Cancer Institute (NCI)
Treatments:
Docetaxel
Pemetrexed